MIXL1 and neoplasm: The bad prognosis value of MIX staining has been confirmed in chemotherapeutic-treated patients’ cohort, supporting that the MIX could also be likely to predict patients’ treatment outcome at early stages and maybe in future to prevent tumor burden by early detection of recurrence.